Inivata is a Leader in Liquid Biopsy

Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients

Inivata is a Leader in Liquid Biopsy

Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients

Liquid Biopsy Unlocking essential genomic information from a simple blood draw to transform the care of cancer patients

InVision® platform

Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients

InVisionFirst®Lung Our US Medicare-reimbursed lead product InVisionFirst®Lung is already transforming the lives of advanced NSCLC patients

InVisionFirst®Lung

Our US Medicare-reimbursed lead product InVisionFirst®Lung is already transforming the lives of advanced NSCLC patients

Radar™  A multi-tumor assay for the detection of residual disease and recurrence based on the InVision® liquid biopsy platform

Radar

A multi-tumor assay for the detection of residual disease and recurrence based on the InVision® liquid biopsy platform

Our Mission

We are transforming the lives of cancer patients and their families through the power of liquid biopsy

InvisionFirst Lung - ctDNA Liquid Biopsy Test

Our Technology - Liquid Biopsy Testing

Our Technology

Contact Us at Inivata

Contact Us

Latest News and Events

US Commercial Launch of InVisionFirst®-Lung

Inivata’s Liquid Biopsy Test for Advanced Non-Small Cell Lung Cancer is Now Available Through NeoGenomics in the US Read More

Circulating tumor DNA genomics reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant metastatic non-small cell lung cancer patients

Sandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazieres, Camille Leonce, Cecile Jovelet, Anne Pradines, ... Read More

Digital World CB & CDx

Digital World CB & CDx

Event expiration date display - 29 Sept - 1 Oct

Location: Virtual Read More

Changing Lives

Patients are at the heart of everything we do.

Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives. 

This is the story of the first patient Inivata tested.

Transforming the lives of Cancer Patients and Their Families

As a dynamic and innovative company, we focus on the development of ground-breaking technology in a fast-paced and international setting.

Our team of talented and driven individuals work together to combine their energy and expertise in world-class research, product development and commercialization. Join us.

We are delighted to be shortlisted as a finalist at the @OBN_UK Awards 2020 in the “Best Established Medtech” category - read more about the awards and the other finalists here: https://obn-awards.com/award-finalists-and-sponsors

It’s been a pleasure working with you all! #liquidbiopsy

Please join NeoGenomics Virtual Tumor Board on liquid biopsy testing in NSCLC August 13 at 12:00 pm EDT. This week's moderator is Dr. Edgardo S. Santos. He is an oncologist with Florida Precision Oncology specializing in thoracic oncology. REGISTER NOW https://bit.ly/33UzKQ3